Chondroitin for Osteoarthritis
Chondroitin may produce a small reduction in osteoarthritis pain in some trials, but the highest-quality independent studies found no real benefit and it does not slow joint damage. Major health authorities consider the evidence too weak to recommend it.
Why this grade7-layer evidence engine
The trial record is genuinely split, which is why this rates as weak evidence rather than a clear yes or no. Older meta-analyses report modest pain relief—around a 10-point drop on a 100-point scale in Cochrane's 2015 review (PMID 25629804), and pain effect sizes of roughly -0.41 to -0.63 (PMID 30859538, PMID 30879253, PMID 29947998). But these analyses are extremely heterogeneous (I²=94%), and the largest, most favorable signal shrinks to a trivial -0.25 once restricted to low-bias, pharmaceutical-grade product. Industry-funded trials consistently look better than independent ones.
The decisive counterweight is the government-funded GAIT trial. With nearly 1,600 patients, chondroitin alone failed its primary pain endpoint versus placebo (p=0.17; PMID 16495392), and its two-year imaging report found no protection of joint space (PMID 18821708). Reviews also note no meaningful effect on cartilage volume or total WOMAC function scores—so any benefit is limited to pain, and even that is uncertain.
Regulators and clinics largely advise against it. The UK NHS no longer prescribes chondroitin and NICE recommends it not be routinely offered; the FDA cleared it only as a food ingredient and rejected its osteoarthritis health claim; EFSA rejected all joint-health claims; Mayo Clinic says it mostly works no better than placebo. A drug-interaction caution also applies—chondroitin may increase bleeding risk with warfarin.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.405
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status